TruBridge, Inc. (TBRG) is a publicly traded company in the Healthcare — Medical - Healthcare Information Services industry listed on NASDAQ. This overview shows the latest price, key valuation ratios, profitability metrics and financial-health indicators used by fundamental investors.
TruBridge, Inc. delivers a comprehensive suite of healthcare solutions and services to community hospitals, clinics, and various medical facilities, both within the United States and globally. Its operations are structured around three core divisions: Revenue Cycle Management (RCM), Electronic Health Record (EHR), and Patient Engagement.
Analysis Summary
TruBridge, Inc. reported revenue of $346.8M in the most recent fiscal year, growing at a 5-year CAGR of 5.6%. Net income reached $4.4M, with a -21.1% 5-year CAGR.
Trailing-twelve-month margins: gross margin 51.2%, operating margin 6.0%, net margin 1.3%. Free cash flow grew at -3.4% CAGR over 5 years.
At the current price of $26.24, TBRG trades at a P/E of 89.31 and an ROE of 2.48%. Market capitalisation stands at $394M.
Balance sheet quality for TBRG: current ratio of 1.8, net debt of $141.9M. A debt-to-equity below 1.0 typically signals conservative capital structure, while a current ratio above 1.5 indicates comfortable short-term liquidity.
Cash flow quality is strong: free cash flow of $35.6M represents 819% conversion of reported net income. High conversion (above 90%) suggests earnings translate cleanly into cash; lower conversion may indicate working capital tightness or accounting timing differences.
Price
| Price | $26.24 |
| Market Cap | $394M |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| P/E Ratio | 89.31 |
| Price / Book | 2.14 |
| EV / EBITDA | 16.17 |
| Dividend Yield | 0.00% |
Profitability
| Return on Equity | 2.48% |
| Return on Invested Capital | -54.87% |
| Return on Assets | 1.08% |
| Gross Margin | 51.23% |
| Operating Margin | 5.96% |
| Net Margin | 1.27% |
Financial Health
| Debt / Equity | 0.94 |
| Current Ratio | 1.78 |
What to look at in Healthcare / Pharma
The R&D pipeline is the invisible asset. Patents expiring = revenues evaporating. Look at innovation and cash flow.
- R&D / Revenue — Shows investment in future pipeline. Serious pharma reinvests 15-20%
- 5y EPS growth — After patent expirations, are they still growing?
- Gross margin — Branded pharma >70%. Generics much lower — defines the business type
- FCF / Net Income — Earnings quality — big pharma should convert >90%
- ROIC — Capital reinvested efficiently — key in pharma due to long R&D cycles
- Net debt / EBITDA — Pharma acquisitions pile up debt — watch the post-M&A picture
- P/E vs own 10y history — The best comparison is with its own history, not with peers
Peer Comparison
| Symbol | Company | Market Cap | P/E | P/B | ROE |
|---|---|---|---|---|---|
| TBRG | TruBridge, Inc. | $394M | 89.31 | 2.14 | 2.5% |
| BTSG | BrightSpring Health Services, Inc. Common Stock | $11.5B | 41.59 | 5.98 | |
| TEM | Tempus AI, Inc. | $12.3B | 22.79 | -49.9% | |
| HQY | HealthEquity, Inc. | $8.1B | 34.54 | 4.05 | |
| HNGE | Hinge Health, Inc. | $7.3B | |||
| WAY | Waystar Holding Corp. | $5.1B | 36.93 | 1.28 | 3.6% |
| DOCS | Doximity, Inc. | $4.8B | 29.31 | 5.20 | |
| HTFL | Heartflow, Inc. Common Stock | $4.2B | 14.82 | -42.3% |
Price Performance
| 1 month | +0.00% |
| 3 months | +0.57% |
| Year-to-date | +18.89% |
| 1 year | +25.97% |
| 3 years | +73.89% |
52-Week Range
| 52-week High | $26.51 |
| 52-week Low | $13.88 |
| Avg Volume (90d) | 281K |
Dividend History
| Date | Amount | Yield |
|---|---|---|
| 2020-08-14 | $0.1000 | 1.52% |
| 2020-05-14 | $0.1000 | 1.52% |
| 2020-02-20 | $0.1000 | 1.52% |
| 2019-11-14 | $0.1000 | 1.52% |
| 2019-08-15 | $0.1000 | 1.52% |
| 2019-05-15 | $0.1000 | 1.52% |
| 2019-02-28 | $0.1000 | 1.52% |
| 2018-11-14 | $0.1000 | 1.52% |
| 2018-08-15 | $0.1000 | 1.52% |
| 2018-05-16 | $0.1000 | 1.52% |
Related companies: BFC · BTSG · BTSGU · CARL · CCLD · CERT · HCAT
Explore sector: Healthcare · Medical - Healthcare Information Services
More sections of TBRG: Financials · Valuation · Statistics · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks